Etanercept and warts.
Adams
David R
DR
Zaenglein
Andrea L
AL
Hershey
Milton S
MS
D000293:Adolescent; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001171:Arthritis, Juvenile / Q000188:drug therapy*; D003937:Diagnosis, Differential; D000068800:Etanercept; D005260:Female; D005534:Foot Diseases / Q000139:chemically induced* / Q000175:diagnosis; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects*; D018124:Receptors, Tumor Necrosis Factor; D011993:Recombinant Fusion Proteins / Q000009:adverse effects*; D014409:Tumor Necrosis Factor-alpha / Q000009:adverse effects; D014860:Warts / Q000139:chemically induced* / Q000175:diagnosis
D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D011993:Recombinant Fusion Proteins; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept